Damora Therapeutics DMRA Income Statement (2019-2026)

NASDAQ DMRA
$20.66 -0.09 (-0.43%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Damora Therapeutics Quarterly Income Statement

Periods 28 quarters
Latest Jun 2026

Damora Therapeutics reported net income of -$31.22M for the quarter ended Jun 2026. This income statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & DevelopmentR&D
9.75M10.12M13.23M13.71M10.49M10.77M10.36M8.09M2.55M2.77M2.46M1.83M1.09M1.01M0.68M1.47M1.42M23.32M23.78M25.54M
Selling, General & AdministrativeSG&A
3.19M3.35M3.70M3.41M3.13M2.75M3.13M3.07M3.30M3.18M3.28M2.77M2.75M1.70M1.92M1.96M1.74M4.07M7.03M9.45M
Restructuring CostsRestructuring
2.73M0.72M0.97M
Other Operating ExpensesOther Opex
4.39M174.31M
Operating ExpensesOpex
12.94M13.47M16.94M17.12M13.62M13.53M13.49M11.16M8.58M6.67M5.74M5.58M3.84M7.10M2.60M3.42M3.16M201.70M30.81M34.99M
Operating IncomeOp. Inc
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-11.16M-8.58M-6.67M-5.74M-5.58M-3.84M-7.10M-2.60M-3.42M-3.16M-201.70M-30.81M-34.99M
EBIT
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-11.16M-8.58M-6.67M-5.74M-5.58M-3.84M-7.10M-2.60M-3.42M-3.16M-201.70M-30.81M-34.99M
Non-operating items
Non Operating Investment IncomeNon-Op. Investment Inc.
0.03M-0.05M-0.20M-0.15M-0.08M0.18M0.09M0.03M0.06M0.06M0.03M0.00M
Other Non Operating IncomeOther Non Op Inc.
0.21M0.03M-0.06M0.15M-0.33M-0.83M0.06M-0.03M-0.03M-0.21M0.01M0.07M-0.18M0.12M-0.01M-0.06M-0.02M0.00M0.02M
Non Operating IncomeNon Op. Inc.
0.24M0.06M0.00M0.23M-0.11M-0.54M0.50M0.41M0.45M0.20M0.26M0.28M-0.04M0.35M0.07M-0.01M0.02M1.00M3.07M4.08M
Net income details
EBT
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-10.74M-8.14M-6.47M-5.48M-5.30M-3.88M-6.75M-2.53M-3.43M-3.13M-200.69M-27.74M-30.92M
Tax ProvisionsTaxes
0.04M0.01M-0.01M0.00M0.00M0.04M0.04M0.30M
Profit After TaxPAT
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-10.74M-8.14M-6.47M-5.48M-5.34M-3.88M-6.74M-2.53M-3.44M-3.13M-200.74M-27.78M-31.22M
Income from Continuing OperationsIncome (Continuing)
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-10.74M-8.14M-6.47M-5.48M-5.34M-3.88M-6.74M-2.53M-3.44M-3.13M-200.74M-27.78M-31.22M
Consolidated Net IncomeConsol Net Inc.
-12.94M-13.47M-16.94M-17.12M-13.62M-13.53M-13.49M-10.74M-8.14M-6.47M-5.48M-5.34M-3.88M-6.74M-2.53M-3.44M-3.13M-200.74M-27.78M-31.22M
Income towards Parent CompanyParent Net Inc
-12.70M-13.41M-16.94M-16.89M-13.73M-14.07M-12.99M-10.74M-8.14M-6.47M-5.48M-5.34M-3.88M-6.74M-2.53M-3.44M-3.13M-200.74M-27.78M-31.17M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-12.70M-13.41M-16.94M-16.89M-13.73M-14.07M-12.99M-10.74M-8.14M-6.47M-5.48M-5.34M-3.88M-6.74M-2.53M-3.44M-3.13M-200.74M-27.78M-31.17M
Additional items
EPS (Basic)
-0.50-0.53-0.67-0.67-0.54-0.55-0.51-0.41-0.30-0.24-0.20-0.20-3.39-5.83-1.92-2.60-2.36-146.35-0.81-0.51
EPS (Diluted)
-0.50-0.53-0.67-0.67-0.54-0.55-0.51-0.41-0.30-0.24-0.20-0.20-3.39-5.83-1.92-2.60-2.36-146.35-0.81-0.51
Shares Outstanding
25.26M25.26M25.26M25.27M25.49M25.41M25.67M26.38M27.10M26.57M27.11M27.12M1.14M1.16M1.32M1.32M1.33M1.37M34.34M61.14M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
25.26M25.26M25.26M25.27M25.49M25.41M25.67M26.38M27.10M26.57M27.11M27.12M1.14M1.16M1.32M1.32M1.33M1.37M34.34M61.14M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
25.26M25.26M25.26M25.34M25.58M25.65M25.67M27.02M27.11M27.11M27.11M27.12M1.25M1.32M1.32M1.32M1.33M1.37M34.34M61.73M
EBITDA
-12.93M-13.46M-16.93M-17.11M-13.62M-13.50M-13.47M-11.14M-8.37M-6.62M-5.74M-5.57M-3.83M-7.10M-2.59M-3.42M-3.15M-201.69M-30.81M-34.99M

Damora Therapeutics Income Statement API

Pull Damora Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DMRA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY